Time course of bleomycin-induced lung fibrosis

被引:382
作者
Izbicki, G
Segel, MJ
Christensen, TG
Conner, MW
Breuer, R
机构
[1] Hadassah Univ Hosp, Inst Pulmonol, Lung Cellular & Mol Biol Lab, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel
[3] Boston Univ, Sch Med, Dept Pathol, Mallory Inst Pathol, Boston, MA 02118 USA
关键词
bleomycin; computer-assisted morphometry; fibrosis; interstitial lung disease; lung; mice;
D O I
10.1046/j.1365-2613.2002.00220.x
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
Intratracheal instillation (IT) of bleomycin is a widely used experimental model for lung fibrosis. In this study we describe the time-course of bleomycin-induced lung fibrosis in mice using computer-assisted morphometry. C57Bl/6J mice were treated with a single IT dose of bleomycin or control saline. Animals were killed 3, 6, 14 and 21 days post-IT. Lung injury was evaluated by analysis of bronchoalveolar lavage (BAL) fluid, hydroxyproline concentration in the lung, routine light microscopic examination resulting in a semiquantitative morphological index (SMI) of lung injury, and quantitative morphological measurements (fibrosis fraction and alveolar wall area fraction) aided by optimas image analysis software. Changes in BAL fluid attributed to bleomycin treatment include increased total cell count (days 14 and 21), and increased percentage of neutrophils (days 3 and 6) followed by a sustained increase in lymphocytes (days 6, 14 and 21). Hydroxyproline levels increased in bleomycin-treated mice on days 14 and 21. Median SMI grades were significantly elevated on days 3, 14 and 21. Computer-assisted morphometry demonstrated a 3-fold increase in fibrosis fraction and a 1.3-fold increase in wall area fraction in bleomycin-treated mice on day 14, with no further increase on day 21. These data also demonstrate that the most suitable time point for assessing lung fibrosis in this model is 14 days after IT instillation of bleomycin, based on the observation that at 14 days the animals developed extensive fibrosis, but had less variability in the fibrotic response and lower mortality than later at 21 days. Computer-assisted morphometry provides objective and quantitative measurements that are a useful tool for the evaluation of bleomycin-induced lung injury.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 45 条
[1]
Human recombinant inteuferon-α2a and interferon-αA/D have different effects on bleomycin-induced lung injury [J].
Berkman, N ;
Kremer, S ;
Or, R ;
Lossos, IS ;
Christensen, TG ;
Goldstein, RH ;
Breuer, R .
RESPIRATION, 2001, 68 (02) :169-177
[2]
EXPERIMENTAL IMMUNE-COMPLEX DISEASE OF LUNG - PATHOGENESIS OF A LABORATORY MODEL RESEMBLING CERTAIN HUMAN INTERSTITIAL LUNG-DISEASES [J].
BRENTJENS, JR ;
OCONNELL, DW ;
PAWLOWSKI, IB ;
HSU, KC ;
ANDRES, GA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1974, 140 (01) :105-125
[3]
CHANDLER DB, 1983, AM J PATHOL, V112, P170
[5]
DALLAGLIO PP, 1988, RESPIRATION S, V54, P136
[6]
Circulating cytokeratin 8:anti-cytokeratin 8 antibody immune complexes in sera of patients with pulmonary fibrosis [J].
Dobashi, N ;
Fujita, J ;
Ohtsuki, Y ;
Yamadori, I ;
Yoshinouchi, T ;
Kamei, T ;
Tokuda, M ;
Hojo, S ;
Bandou, S ;
Ueda, Y ;
Takahara, J .
RESPIRATION, 2000, 67 (04) :397-401
[7]
Elevation of anti-cytokeratin 18 antibody and circulating cytokeratin 18: Anti-cytokeratin 18 antibody immune complexes in sera of patients with idiopathic pulmonary fibrosis [J].
Dobashi, N ;
Fujita, J ;
Murota, M ;
Ohtsuki, Y ;
Yamadori, I ;
Yoshinouchi, T ;
Ueda, R ;
Bandoh, S ;
Kamei, T ;
Nishioka, M ;
Ishida, T ;
Takahara, J .
LUNG, 2000, 178 (03) :171-179
[8]
DIFFUSE PULMONARY INTERSTITIAL DISEASE - IMMUNOHISTOLOGIC STUDY [J].
EISENBERG, H ;
SIMMONS, DH ;
BARNETT, EV .
CHEST, 1979, 75 (02) :262-264
[9]
IMMUNOLOGICAL INVOLVEMENT IN PULMONARY FIBROSIS INDUCED BY PEPLOMYCIN [J].
EKIMOTO, H ;
AIKAWA, M ;
OHNUKI, T ;
TAKAHASHI, K ;
MATSUDA, A ;
TAKITA, T ;
UMEZAWA, H .
JOURNAL OF ANTIBIOTICS, 1985, 38 (01) :94-98
[10]
ENDO Y, 1990, ACTA PATHOL JAPON, V40, P239